应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
06855 亚盛医药-B
已收盘 07-29 16:08:29
77.850
+0.300
+0.39%
最高
78.950
最低
75.950
成交量
435.35万
今开
77.000
昨收
77.550
日振幅
3.87%
总市值
289.60亿
流通市值
289.60亿
总股本
3.72亿
成交额
3.37亿
换手率
1.17%
流通股本
3.72亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
特朗普再喊话:美联储必须降息!美股小幅上涨,金价急跌!这只中概股大涨超20%
每经网 · 07-28 15:40
特朗普再喊话:美联储必须降息!美股小幅上涨,金价急跌!这只中概股大涨超20%
亚盛医药-B07月28日主力净流入1448.9万元 散户资金抛售
市场透视 · 07-28 08:15
亚盛医药-B07月28日主力净流入1448.9万元 散户资金抛售
智通港股早知道 | 农业农村部等发布促进农产品消费实施方案 AI投资联盟正式成立
智通财经 · 07-27 23:20
智通港股早知道 | 农业农村部等发布促进农产品消费实施方案 AI投资联盟正式成立
亚盛医药-B完成先旧后新配售2200万股股份 净筹约14.925亿港元
智通财经 · 07-25
亚盛医药-B完成先旧后新配售2200万股股份 净筹约14.925亿港元
亚盛医药-B(06855.HK)完成先旧后新配售2200万股股份 净筹约14.925亿港元
智通财经 · 07-25
亚盛医药-B(06855.HK)完成先旧后新配售2200万股股份 净筹约14.925亿港元
亚盛医药-B07月24日主力净流入320.3万元 散户资金抛售
市场透视 · 07-24
亚盛医药-B07月24日主力净流入320.3万元 散户资金抛售
亚盛医药-B07月23日主力净流出5563.5万元 散户资金买入
市场透视 · 07-23
亚盛医药-B07月23日主力净流出5563.5万元 散户资金买入
亚盛医药-B07月21日主力净流出2938.9万元 散户资金买入
市场透视 · 07-21
亚盛医药-B07月21日主力净流出2938.9万元 散户资金买入
亚盛医药-B盘中异动 早盘急速上涨5.01%
市场透视 · 07-18
亚盛医药-B盘中异动 早盘急速上涨5.01%
首个国产原研!亚盛医药创新抗癌药国内获批上市,影响有多大?
澎湃新闻 · 07-17
首个国产原研!亚盛医药创新抗癌药国内获批上市,影响有多大?
每日卖空追踪 | 亚盛医药-B 07月16日卖空量成交54.03万股,卖空比例为6.01%
市场透视 · 07-16
每日卖空追踪 | 亚盛医药-B 07月16日卖空量成交54.03万股,卖空比例为6.01%
亚盛医药-B07月16日获主力加仓1432.6万元
市场透视 · 07-16
亚盛医药-B07月16日获主力加仓1432.6万元
创新药概念走势向好 复宏汉霖涨9.72% 机构指板块估值仍具吸引力
金吾财讯 · 07-16
创新药概念走势向好 复宏汉霖涨9.72% 机构指板块估值仍具吸引力
港股异动 | 亚盛医药(06855)午前涨超4% 公司配股净筹近15亿港元 加速商业化及创新药研发
智通财经 · 07-16
港股异动 | 亚盛医药(06855)午前涨超4% 公司配股净筹近15亿港元 加速商业化及创新药研发
每日卖空追踪 | 亚盛医药-B 07月15日卖空量成交109.17万股,卖空比例为2.63%
市场透视 · 07-15
每日卖空追踪 | 亚盛医药-B 07月15日卖空量成交109.17万股,卖空比例为2.63%
越疆折价配股合共净筹约25亿港元 盘初股价均走低
金吾资讯 · 07-15
越疆折价配股合共净筹约25亿港元 盘初股价均走低
亚盛医药-B盘中异动 早盘快速下挫5.42%报70.650港元
市场透视 · 07-15
亚盛医药-B盘中异动 早盘快速下挫5.42%报70.650港元
2025年医药行业发展动态与趋势洞察——资本运作与市场表现分析
报告大厅 · 07-15
2025年医药行业发展动态与趋势洞察——资本运作与市场表现分析
亚盛医药-B拟先旧后新配售最多2200万股销售股份 净筹14.93亿港元
智通财经 · 07-14
亚盛医药-B拟先旧后新配售最多2200万股销售股份 净筹14.93亿港元
亚盛医药拟配股筹资最多15.4亿港元
DoNews · 07-14
亚盛医药拟配股筹资最多15.4亿港元
加载更多
公司概况
公司名称:
亚盛医药-B
所属市场:
SEHK
上市日期:
--
主营业务:
亚盛医药集团是一家主要从事血液系统恶性肿瘤治疗药物的发现、研发及商业化的控股公司。该公司主营业务是从事开发及销售针对肿瘤、乙肝及衰老相关的疾病的新型小规模疗法。该公司的主要产品包括Olverembatinib(HQP1351)、Lisaftoclax(APG-2575)、Alrizomadlin(APG-115)、Pelcitoclax(APG-1252)、APG-5918等产品。该公司的产品主要用于治疗主要血液系统恶性肿瘤,包括慢性粒细胞白血病、急性粒细胞白血病、慢性淋巴细胞白血病、急性淋巴细胞白血病、骨髓增生异常综合征及多发性骨髓瘤。该公司主要在国内市场开展业务。
发行价格:
--
{"stockData":{"symbol":"06855","market":"HK","secType":"STK","nameCN":"亚盛医药-B","latestPrice":77.85,"timestamp":1753776509005,"preClose":77.55,"halted":0,"volume":4353533,"delay":0,"floatShares":372000000,"shares":372000000,"eps":-1.4666303978286979,"marketStatus":"已收盘","change":0.3,"latestTime":"07-29 16:08:29","open":77,"high":78.95,"low":75.95,"amount":336827366,"amplitude":0.038685,"askPrice":77.85,"askSize":2900,"bidPrice":77.7,"bidSize":5000,"shortable":3,"etf":0,"ttmEps":-1.4666303978286979,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753839000000},"marketStatusCode":5,"adr":0,"listingDate":1572192000000,"exchange":"SEHK","adjPreClose":77.55,"openAndCloseTimeList":[[1753752600000,1753761600000],[1753765200000,1753776000000]],"volumeRatio":0.84707,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06855","defaultTab":"news","newsList":[{"id":"2554708953","title":"特朗普再喊话:美联储必须降息!美股小幅上涨,金价急跌!这只中概股大涨超20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554708953","media":"每经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554708953?lang=zh_cn&edition=full","pubTime":"2025-07-28 23:40","pubTimestamp":1753717220,"startTime":"0","endTime":"0","summary":"央视新闻消息,当地时间7月28日,美国总统特朗普表示,美联储必须降息。美联储主席鲍威尔任期至2026年5月结束。当地时间27日,特朗普与冯德莱恩达成一致,双方同意实行统一的15%关税税率。特朗普表示,欧盟将比此前增加对美国投资6000亿美元,欧盟将购买美国军事装备,并将购买价值7500亿美元的美国能源产品冯德莱恩表示,协议中对汽车行业的关税统一定为15%。冯德莱恩称,这些与美国的贸易协议将为市场带来稳定性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072823405697237ccd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072823405697237ccd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06855","ZLAB","BK1161","BK1574","TSLA","ELPW","09688","AAPG"],"gpt_icon":0},{"id":"2554775356","title":"亚盛医药-B07月28日主力净流入1448.9万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2554775356","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554775356?lang=zh_cn&edition=full","pubTime":"2025-07-28 16:15","pubTimestamp":1753690559,"startTime":"0","endTime":"0","summary":"07月28日, 亚盛医药-B股价涨4.59%,报收77.55元,成交金额2.7亿元,换手率0.94%,振幅5.46%,量比0.66。亚盛医药-B今日主力资金净流入1448.9万元,上一交易日主力净流出2902.2万元。该股近5个交易日上涨0.13%,主力资金累计净流出4358.8万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入9800.7万元,其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728170119a6c5a5dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728170119a6c5a5dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06855","BK1161","BK1574"],"gpt_icon":0},{"id":"2554464317","title":"智通港股早知道 | 农业农村部等发布促进农产品消费实施方案 AI投资联盟正式成立","url":"https://stock-news.laohu8.com/highlight/detail?id=2554464317","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554464317?lang=zh_cn&edition=full","pubTime":"2025-07-28 07:20","pubTimestamp":1753658445,"startTime":"0","endTime":"0","summary":"农业农村部等十部门发布促进农产品消费实施方案为贯彻落实党中央、国务院关于大力提振消费的决策部署,有力有效扩大农产品消费,农业农村部、国家发展改革委、教育部、工业和信息化部、商务部、文化和旅游部、国家卫生健康委、市场监管总局、体育总局、国家知识产权局联合制定了《促进农产品消费实施方案》。AI投资联盟正式成立7月27日,“AI投资联盟”在2025世界人工智能大会期间举行的2025中国电信人工智能生态论坛上正式成立。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1322337.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["YANG","LU0605514214.HKD","LU0084288322.USD","LU2237443549.SGD","LU0149721374.USD","LU0417516738.SGD","LU2039709279.SGD","IE00BZ08YT58.USD","LU0786609619.USD","SG9999002562.SGD","LU0577902454.USD","LU0029875118.USD","LU1048596156.SGD","BK1618","BK4614","LU0320764599.SGD","LU0067412154.USD","LU0164865239.USD","00700","IE00BPRC5H50.USD","SG9999014914.USD","LU0608807946.USD","LU1366334578.USD","HTCD.SI","HSCEI","HSTECH","LU0516423174.USD","LU1196710351.USD","LU0878004406.USD","000061","LU0348827113.USD","LU0326948709.USD","LU2097828714.EUR","SG9999006514.SGD","TCHmain","LU2462611646.USD","IE0008369823.USD","06855","LU0072913022.USD","LU0918141705.HKD","LU0821914370.USD","LU1226287875.USD","LU0572940350.SGD","LU2279701549.SGD","LU1439103000.SGD","IE0008368411.USD","LU0540923850.HKD","LU0096374516.USD"],"gpt_icon":1},{"id":"2554937107","title":"亚盛医药-B完成先旧后新配售2200万股股份 净筹约14.925亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554937107","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554937107?lang=zh_cn&edition=full","pubTime":"2025-07-25 20:44","pubTimestamp":1753447440,"startTime":"0","endTime":"0","summary":"配售代理已根据配售及认购协议的条款及条件按配售价每股销售股份68.60港元向不少于六名承配人成功配售合共2200万股销售股份。由于所有认购事项先决条件亦已获达成,公司已于2025年7月25日向卖方以每股认购股份68.60港元配发及发行2200万股认购股份,净筹约14.925亿港元,拟用于商业化工作,包括扩大覆盖范围和提高患者就医机会;全球临床开发,以推进公司的核心管线在研产品;基础设施及营运资金以加强全球营运。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725204638a46367e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725204638a46367e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","06855"],"gpt_icon":0},{"id":"2554109767","title":"亚盛医药-B(06855.HK)完成先旧后新配售2200万股股份 净筹约14.925亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554109767","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554109767?lang=zh_cn&edition=full","pubTime":"2025-07-25 20:35","pubTimestamp":1753446958,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1574","BK4139","AAPG","BK1161","06855"],"gpt_icon":0},{"id":"2553044242","title":"亚盛医药-B07月24日主力净流入320.3万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2553044242","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553044242?lang=zh_cn&edition=full","pubTime":"2025-07-24 16:15","pubTimestamp":1753344942,"startTime":"0","endTime":"0","summary":"07月24日, 亚盛医药-B股价涨5.77%,报收77.95元,成交金额3.7亿元,换手率1.41%,振幅6.24%,量比0.72。亚盛医药-B今日主力资金净流入320.3万元,上一交易日主力净流出5563.5万元。该股近5个交易日上涨1.69%,主力资金累计净流出4379.4万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入9420.4万元,其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724165756a460ec4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724165756a460ec4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06855","BK1161","BK1574"],"gpt_icon":0},{"id":"2553128213","title":"亚盛医药-B07月23日主力净流出5563.5万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2553128213","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553128213?lang=zh_cn&edition=full","pubTime":"2025-07-23 16:15","pubTimestamp":1753258520,"startTime":"0","endTime":"0","summary":"07月23日, 亚盛医药-B股价跌3.09%,报收73.70元,成交金额5.5亿元,换手率2.13%,振幅5.39%,量比1.04。亚盛医药-B今日主力资金净流出5563.5万元,上一交易日主力净流入2337.6万元。该股近5个交易日下跌0.41%,主力资金累计净流出8922.0万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流入1.1亿元,其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723165240a6bce68b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723165240a6bce68b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","06855"],"gpt_icon":0},{"id":"2553643408","title":"亚盛医药-B07月21日主力净流出2938.9万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2553643408","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553643408?lang=zh_cn&edition=full","pubTime":"2025-07-21 16:15","pubTimestamp":1753085707,"startTime":"0","endTime":"0","summary":"07月21日, 亚盛医药-B股价跌3.07%,报收77.45元,成交金额3.3亿元,换手率1.20%,振幅5.26%,量比0.29。亚盛医药-B今日主力资金净流出2938.9万元,上一交易日主力净流入1465.1万元。该股近5个交易日上涨3.61%,主力资金累计净流入7806.2万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入1.3亿元,其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721164800a458f7bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721164800a458f7bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","06855"],"gpt_icon":0},{"id":"2552456415","title":"亚盛医药-B盘中异动 早盘急速上涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552456415","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552456415?lang=zh_cn&edition=full","pubTime":"2025-07-18 11:10","pubTimestamp":1752808207,"startTime":"0","endTime":"0","summary":"2025年07月18日早盘11时10分,亚盛医药-B股票出现异动,股价急速上涨5.01%。截至发稿,该股报80.650港元/股,成交量428.705万股,换手率1.23%,振幅6.58%。亚盛医药-B股票所在的生物技术行业中,整体涨幅为0.05%。其相关个股中,歌礼制药-B、加科思-B、中国抗体-B涨幅较大,振幅较大的相关个股有歌礼制药-B、三叶草生物-B、北海康成-B,振幅分别为15.03%、14.58%、13.75%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071811100797aa9439&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071811100797aa9439&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06855","BK1574"],"gpt_icon":0},{"id":"2552688105","title":"首个国产原研!亚盛医药创新抗癌药国内获批上市,影响有多大?","url":"https://stock-news.laohu8.com/highlight/detail?id=2552688105","media":"澎湃新闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552688105?lang=zh_cn&edition=full","pubTime":"2025-07-17 14:02","pubTimestamp":1752732157,"startTime":"0","endTime":"0","summary":"Bcl-2抑制剂可特异性地结合并抑制Bcl-2蛋白,有效恢复肿瘤细胞的凋亡通路,诱导癌细胞死亡。此次中国原创、全球创新的药物有望改写全球Bcl-2抑制剂市场的竞争格局。利沙托克拉是亚盛医药第二个获批上市、进入商业化阶段的原创新药,未来是否也会考虑BD?亚盛医药目前已经有两款产品获批,“我们希望2027年做到收支平衡有利润”。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071714035797a95af1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071714035797a95af1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AAPG","BK4139","06855"],"gpt_icon":0},{"id":"2552122596","title":"每日卖空追踪 | 亚盛医药-B 07月16日卖空量成交54.03万股,卖空比例为6.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552122596","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552122596?lang=zh_cn&edition=full","pubTime":"2025-07-16 16:30","pubTimestamp":1752654641,"startTime":"0","endTime":"0","summary":"亚盛医药-B北京时间07月16日,涨2.86%,卖空量成交54.03万股%,较上一交易日减少66.55%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716172912a6ad2307&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716172912a6ad2307&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06855","BK1574","BK1161"],"gpt_icon":0},{"id":"2552594122","title":"亚盛医药-B07月16日获主力加仓1432.6万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552594122","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552594122?lang=zh_cn&edition=full","pubTime":"2025-07-16 16:15","pubTimestamp":1752653740,"startTime":"0","endTime":"0","summary":"07月16日, 亚盛医药-B股价涨2.86%,报收73.85元,成交金额6.6亿元,换手率2.57%,振幅5.29%,量比0.71。亚盛医药-B今日主力资金净流入1432.6万元,连续3日净流入,上一交易日主力净流入1.2亿元。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为58.82%,平均涨幅为3.35%。该股近5个交易日下跌9.62%,主力资金累计净流入7719.7万元;近20日主力资金累计净流入2.5亿元,其中净流入天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716170416a6ad126a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716170416a6ad126a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06855","BK1161","BK1574"],"gpt_icon":0},{"id":"2551124121","title":"创新药概念走势向好 复宏汉霖涨9.72% 机构指板块估值仍具吸引力","url":"https://stock-news.laohu8.com/highlight/detail?id=2551124121","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551124121?lang=zh_cn&edition=full","pubTime":"2025-07-16 13:41","pubTimestamp":1752644466,"startTime":"0","endTime":"0","summary":"金吾财讯 | 创新药概念走势向好,派格生物医药 涨10.83%,复宏汉霖涨9.72%,康方生物涨7.13%,亚盛医药涨4.25%,诺诚健华涨3.5%。对于创新药出海演变方向,该机构观察以下趋势:1)行业进一步衍生出了NewCo等新型交易模式;2)ADC赛道交易兴趣度最高,双抗/多抗、小核酸/mRNA等前沿技术领域亦存在较多机会。基于当前国产创新药资产储备丰富且交易性价比仍显着、MNC存在专利补缺需求、海外投融资边际改善,该机构认为2H25-2026年出海交易热度仍将延续。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716135524a6acadc9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716135524a6acadc9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","06978","09926","06855","BK1161","09969","02696","02565"],"gpt_icon":0},{"id":"2551111185","title":"港股异动 | 亚盛医药(06855)午前涨超4% 公司配股净筹近15亿港元 加速商业化及创新药研发","url":"https://stock-news.laohu8.com/highlight/detail?id=2551111185","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551111185?lang=zh_cn&edition=full","pubTime":"2025-07-16 11:54","pubTimestamp":1752638052,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,亚盛医药午前涨超4%,截至发稿,涨4.11%,报74.75港元,成交额4.95亿港元。消息面上,亚盛医药近日宣布,拟按每股68.60港元的价格发行最多2200万股新股,配售事项所得净额约为14.93亿港元。董事认为,配售事项及认购事项将进一步巩固本集团的财务状况,并为本集团提供额外营运资金。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1318372.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159992","06855","BK4139","AAPG","BK1574","06978","BK1161"],"gpt_icon":0},{"id":"2551816923","title":"每日卖空追踪 | 亚盛医药-B 07月15日卖空量成交109.17万股,卖空比例为2.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551816923","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551816923?lang=zh_cn&edition=full","pubTime":"2025-07-15 16:30","pubTimestamp":1752568234,"startTime":"0","endTime":"0","summary":"亚盛医药-B北京时间07月15日,跌3.88%,卖空量成交109.17万股%,较上一交易日减少23.56%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715172752a44c026e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715172752a44c026e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","06855"],"gpt_icon":0},{"id":"2551132119","title":"越疆折价配股合共净筹约25亿港元 盘初股价均走低","url":"https://stock-news.laohu8.com/highlight/detail?id=2551132119","media":"金吾资讯","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551132119?lang=zh_cn&edition=full","pubTime":"2025-07-15 09:48","pubTimestamp":1752544097,"startTime":"0","endTime":"0","summary":"金吾财讯 | 越疆 及亚盛医药均折价配股抽水,合共净筹约25亿港元,盘初股价均走低。截至发稿,越疆报58.3港元,跌2.83%,成交额5718.93万港元;亚盛医药报71.7港元,跌4.02%,成交额19.13亿港元。公司有90日禁售承诺。亚盛医药宣布,拟先旧后新配售最多2200万股新股份,占扩大后的已发行股本约5.92%,每股配售价为68.6港元,较上交易日收市价74.7港元折让约8.17%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071509485097a65f98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071509485097a65f98&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AAPG","06855"],"gpt_icon":0},{"id":"2551325541","title":"亚盛医药-B盘中异动 早盘快速下挫5.42%报70.650港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551325541","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551325541?lang=zh_cn&edition=full","pubTime":"2025-07-15 09:30","pubTimestamp":1752543007,"startTime":"0","endTime":"0","summary":"2025年07月15日早盘09时30分,亚盛医药-B股票出现波动,股价大幅跳水5.42%。截至发稿,该股报70.650港元/股,成交量2325.25万股,换手率6.66%,振幅0.80%。亚盛医药-B股票所在的生物技术行业中,整体涨幅为0.19%。该信息摘要如下:中金发布研报称,考虑到利生妥获批上市及全球适应症拓展前景,维持亚盛医药-B跑赢行业评级,根据DCF模型,上调目标价27.5%至88港币,较当前股价有15.3%的上行空间。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507150930089542c63c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507150930089542c63c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","06855","BK1161"],"gpt_icon":0},{"id":"2551813173","title":"2025年医药行业发展动态与趋势洞察——资本运作与市场表现分析","url":"https://stock-news.laohu8.com/highlight/detail?id=2551813173","media":"报告大厅","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551813173?lang=zh_cn&edition=full","pubTime":"2025-07-15 08:20","pubTimestamp":1752538840,"startTime":"0","endTime":"0","summary":"中国报告大厅网讯,2025年的医药行业正经历深刻变革,政策推动、技术创新与资本市场活跃度持续提升。今日发布的亚盛医药-B配售及认购公告,再次印证了医药企业在融资策略上的前瞻性,为行业提供了新的观察视角。大额融资将进一步强化亚盛在医药研发领域的资源储备,尤其在肿瘤、抗病毒等核心赛道的管线推进中发挥关键作用。亚盛此次交易不仅补充了流动性,更巩固了其在创新药领域的竞争力,为后续临床试验及商业化落地提供坚实后盾。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071508363697a64acb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071508363697a64acb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","06855","BK1161"],"gpt_icon":0},{"id":"2551332139","title":"亚盛医药-B拟先旧后新配售最多2200万股销售股份 净筹14.93亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551332139","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551332139?lang=zh_cn&edition=full","pubTime":"2025-07-15 06:30","pubTimestamp":1752532200,"startTime":"0","endTime":"0","summary":"预期认购事项将筹集的所得款项总额将约为15.09亿港元及估计认购事项产生的所得款项净额将约为 14.93亿港元。按此基准,每股销售股份的净价将约为67.84港元。董事认为,配售事项及认购事项将进一步巩固本集团的财务状况,并为本集团提供额外营运资金。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715063216a6a986a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715063216a6a986a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","06855"],"gpt_icon":0},{"id":"2551188991","title":"亚盛医药拟配股筹资最多15.4亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551188991","media":"DoNews","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551188991?lang=zh_cn&edition=full","pubTime":"2025-07-14 19:13","pubTimestamp":1752491583,"startTime":"0","endTime":"0","summary":"2025年7月14日,交易文件显示,亚盛医药计划通过先旧后新方式配售股份,预计筹资至多15.4亿港元(约1.96亿美元)。公司拟配售2,200万股股份,每股配售价在68.35至70港元之间,较上周一收盘价74.70港元折让6.3%-8.5%。此次配股旨在增强公司资金流动性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714191420954206e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714191420954206e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ASPHF","06855","BK4139","AAPG"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ascentagepharma.com","stockEarnings":[{"period":"1week","weight":0.0013},{"period":"1month","weight":0.0013},{"period":"3month","weight":0.6275},{"period":"6month","weight":1.2842},{"period":"1year","weight":1.8722},{"period":"ytd","weight":0.7063}],"compareEarnings":[{"period":"1week","weight":0.0227},{"period":"1month","weight":0.0526},{"period":"3month","weight":0.1615},{"period":"6month","weight":0.2639},{"period":"1year","weight":0.5018},{"period":"ytd","weight":0.2743}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"亚盛医药集团是一家主要从事血液系统恶性肿瘤治疗药物的发现、研发及商业化的控股公司。该公司主营业务是从事开发及销售针对肿瘤、乙肝及衰老相关的疾病的新型小规模疗法。该公司的主要产品包括Olverembatinib(HQP1351)、Lisaftoclax(APG-2575)、Alrizomadlin(APG-115)、Pelcitoclax(APG-1252)、APG-5918等产品。该公司的产品主要用于治疗主要血液系统恶性肿瘤,包括慢性粒细胞白血病、急性粒细胞白血病、慢性淋巴细胞白血病、急性淋巴细胞白血病、骨髓增生异常综合征及多发性骨髓瘤。该公司主要在国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.093585},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.035469},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.10554},{"month":4,"riseRate":0.833333,"avgChangeRate":0.119495},{"month":5,"riseRate":0.5,"avgChangeRate":0.054537},{"month":6,"riseRate":0.833333,"avgChangeRate":0.306068},{"month":7,"riseRate":0.5,"avgChangeRate":-0.064934},{"month":8,"riseRate":0.8,"avgChangeRate":0.030238},{"month":9,"riseRate":0.2,"avgChangeRate":-0.085141},{"month":10,"riseRate":0.6,"avgChangeRate":0.075164},{"month":11,"riseRate":0.5,"avgChangeRate":0.0779},{"month":12,"riseRate":0.666667,"avgChangeRate":0.084992}],"exchange":"SEHK","name":"亚盛医药-B","nameEN":"ASCENTAGE-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"亚盛医药-B(06855)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供亚盛医药-B(06855)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"亚盛医药-B,06855,亚盛医药-B股票,亚盛医药-B股票老虎,亚盛医药-B股票老虎国际,亚盛医药-B行情,亚盛医药-B股票行情,亚盛医药-B股价,亚盛医药-B股市,亚盛医药-B股票价格,亚盛医药-B股票交易,亚盛医药-B股票购买,亚盛医药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"亚盛医药-B(06855)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供亚盛医药-B(06855)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}